KIRKLAND, Wash., July 27, 2011 /PRNewswire/ -- A recent study published in the peer-reviewed national medical journal, Neurology, found that common drugs used to treat multiple sclerosis (MS) provide only modest health gains and come at a very high cost in the United States. Local Evergreen He
↧